IVERMECTIN CONVERTS COLD TUMORS HOT AND SYNERGIZES WITH IMMUNE CHECKPOINT BLOCKADE FOR TREATMENT OF BREAST CANCER
ANTIBIOTIC IVERMECTIN PREFERENTIALLY TARGETS RENAL CANCER
IVERMECTIN AS AN INHIBITOR OF CANCER STEM-LIKE CELLS

Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer
pubmed.ncbi.nlm.nih.gov/33654071/
We show that treatment with the FDA-approved anti-parasitic drug ivermectin induces immunogenic cancer cell death (ICD) and robust T cell infiltration ...

Ivermectin as an inhibitor of cancer stem‑like cells
http://pubmed.ncbi.nlm.nih.gov/29257278/

ANTIBIOTIC IVERMECTIN PREFERENTIALLY TARGETS RENAL CANCER
IVERMECTIN AS AN INHIBITOR OF CANCER STEM-LIKE CELLS
IVERMECTIN CAN SURPRESS OVARIAN CANCER
https://t.me/DisclosureLibrary/15069
https://t.me/DisclosureLibrary/15067
https://t.me/DisclosureLibrary/15070